PIII Stock Surges 388% in 1 Month — Profit Turnaround & Strong Momentum

Quick overview

P3 Health Partners Company’s stock has wiped out all previous shortcomings and has caught a very strong upward momentum. In the past one month, it has shown an increase of approximately 388.89 percent, and in the last five days, an increase of around 50 percent has been seen. If we talk about today, the stock has shown slight losses of approximately 4.76 percent, but these are not such major losses that they could overshadow its previous performance or eliminate its impact.

A few days ago, on May 14, this stock was trading at only $4.03. After that day, it caught such rapid upward momentum that the stock touched $13.86 on May 21, and today this stock is trading at $13.20, which overall is showing a very positive performance.

Company Introduction and Overview

P3 Health Partners is a company that works as a support team between doctors, patients, and insurance companies. Their main focus is to keep people healthy and to provide extra care to those who are sick. Along with this, they help patients find a good doctor, guide patients about tests, and also guide them about which treatment they should take.

They also help patients in managing long-term diseases such as diabetes and blood pressure, and assist them in arranging their regular checkups. In addition, due to this company, patients are able to avoid many hospital visits, and they also provide medicine reminders to their patients. Overall, they are working for the well-being of patients.

On the other hand, this company also helps doctors a lot because doctors normally spend a lot of their time on paperwork, insurance claims, and admin work. So what this company does is that it handles the paperwork itself in order to save their time so that doctors can get more time to treat patients. Apart from this, this company also provides doctors with useful data, technology, and extra staff support as well.

Company Shows Strong First Quarter Growth

The proof of this company’s positive performance is also given by its first quarter 2026 report, which was very positive and showed a lot of improvement. This proves that this company has grown in a very good way. For example, their total revenue was $386 million, which means they made sales of $386 million in three months. This is 4 percent higher than the same time last year.

Apart from this, the company made a profit of $3 million in net income, while last time they had a loss of $44 million in the first quarter 2025. From here you can estimate how this company is covering its old losses and is further growing.

Company Growing Strong and Confident

Seeing all this positive upward movement, this company has also increased its full year 2026 target. That is why we are expecting that they will make sales of $1.5 billion to $1.65 billion in the whole year, and their adjusted EBITDA will be between $20 million and $60 million. This confidence itself shows that this company is progressing on a very good track. The leaders of this company are very determined and confident about its future growth.

They believe this company will grow further in the coming time because of their better contracts with insurance companies and medical care plans. Their one specialty is that they control costs in a very good way for patients, so this is a very big plus point for them, and investors are also liking this thing about them very much.

ABOUT THE AUTHOR See More

Arslan Butt

Lead Markets Analyst – Multi-Asset (FX, Commodities, Crypto)

Arslan Butt serves as the Lead Commodities and Indices Analyst, bringing a wealth of expertise to the field. With an MBA in Behavioral Finance and active progress towards a Ph.D., Arslan possesses a deep understanding of market dynamics. His professional journey includes a significant role as a senior analyst at a leading brokerage firm, complementing his extensive experience as a market analyst and day trader. Adept in educating others, Arslan has a commendable track record as an instructor and public speaker. His incisive analyses, particularly within the realms of cryptocurrency and forex markets, are showcased across esteemed financial publications such as ForexCrunch, InsideBitcoins, and EconomyWatch, solidifying his reputation in the financial community.

PIII Stock Surges 388% in May 2026 — Hits $13.20 on Strong Earnings

1 day ago

Save